Skip to content
healthcare.dev

Icatibant

NDC 63323-574, Icatibant, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-574
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208317
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-574 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ICATIBANT ACETATE10 mg/mL

Pharmacologic classes

Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]

Package NDCNDC-11Package
63323-574-86633230574861 SYRINGE in 1 CARTON (63323-574-86) / 3 mL in 1 SYRINGE (63323-574-01)
63323-574-93633230574933 CARTON in 1 BOX (63323-574-93) / 1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/52c12c15-c00b-4efc-952d-1425c907706a

Use it

Look up 63323-574 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-574 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-574. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.